Presented by:
Sponsored by:
Cleveland Society of Obstetricians and Gynecologists
Topic: “Skin” ny or Not
Moderator: Vicki Reed, MD
March 12, 2014 1:00-5:00 pm
DoubleTree Hotel at Rockside and I-77
1:00 p.m.
Welcome by Vicki Reed, MD, President
1:05 p.m.
What is New in Genital Dermatology?
Natasha Atanaskova Mesinkovska, MD, PhD
Department of Dermatology, Cleveland Clinic
Department of Dermatopathology, Cleveland Clinic
Department of Biochemistry, Case Western University SOM
1:45 p.m.
Eating Disorders and Pregnancy
Mark Warren, MD
Founder and Medical Director, Cleveland Center for Eating Disorders
Assistant Clinical Professor of Psychiatry, Case Western Reserve University School of Medicine,
Cleveland, Ohio
2:25 p.m.
"I Don’t Want That, My Cousin Had it and…”: Breaking Down the Myths About Contraception
Lisa K. Perriera MD, MPH
Assistant Professor of OB/GYN
Section Chief of Family Planning
University Hospitals, Case Medical Center
3:05-3:35 p.m.
Refreshment Break
3: 35 p.m.
Can We Prevent Pelvic Floor Disorders?
Matthew Barber, MD, MHS
Professor and Vice Chair for Clinical Research, Obstetrics, Gynecology and Women’s Health
Institute
Fellowship Director, Female Pelvic Medicine and Reconstructive Pelvic Surgery
Cleveland Clinic
4:15 p.m.
Pregnancy after Gastric Bypass
Bradley Stetzer, DO
Maternal-Fetal Medicine
Department of Obstetrics and Gynecology
MetroHealth Medical Center
5:00 p.m.
Raffle and Adjourn
LEARNING OBJECTIVES & PROFESSIONAL PRACTICE GAP(S)
After this session, participants will be able to:
1. Describe common genital dermatosis
2. Discuss recent developments in mechanisms of disease of genital dermatosis
3. Recognize emerging therapeutic options for common genital dermatosis
4. Describe the central features of specific eating disorders
5. Explain fertility rates for patients with an eating disorder history
6. Recognize the pregnancy risks for patients with an eating disorder history
7. Utilize nutrition principles in the care of pregnant patients with an eating disorder history
8. Recognize patient-centered initiation of long acting reversible contraception
9. Discuss the commonly held myths surrounding different contraceptive options
10. Realize how to handle some of the more common contraceptive side effects
11. Describe our current understanding of the pathophysiology of pelvic floor disorders
12. Outline potential strategies for preventing pelvic floor disorders including weight loss, pelvic muscle
exercises and behavioral changes
13. Introduce an individualized prediction model for predicting risk of urinary and fecal incontinence after
childbirth and discuss its potential use for decreasing the risk of pelvic floor disorders
14. Discuss the different types of gastric bypass
15. Discuss pregnancy after gastric bypass
16. Explain the potential fetal complications if the mom has had gastric bypass
Practice Gap(s) for this session: The Practice Gap is the reason a conference or CME activity needs to be held. It
describes the difference between where a group of learners/field of study/ practice currently is (current status)
and where the learning/practice should be (desired status). The "gap" between the current and the desired will be
used to identify conference needs, purposes, objectives, and desired outcomes.
1.
2.
3.
4.
5.
6.
Customize treatment of pregnant patients with various BMI needs, surgically and medically
Recognize myths vs data driven decisions regarding long acting contraceptive options
Review specific needs and cautions regarding pregnant patients who have under gone gastric bypass
Realize difference between common vs. concerning vulvar lesions
Identify current emphasis in field of pelvic prolapse
Identify associated specific risks in patients with polarized BMI
ACCREDITATION
Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing
Medical Education to provide continuing medical education for physicians.
Case Western Reserve University School of Medicine designates this live activity for a maximum of 3.5 AMA PRA
Category 1 Credit.TM. Physicians should claim only the credit commensurate with the extent of their participation
in the activity.
DISCLOSURE
The policy of Case Western Reserve University School of Medicine CME Program requires that the Activity Director,
planning committee members and all activity faculty (that is, anyone in a position to control the content of the
education activity) disclose to the activity participants all relevant financial relationships with commercial interests.
Disclosure will be made to activity participants prior to the commencement of the activity. Case Western Reserve
University School of Medicine also requires that faculty make clinical recommendations based on the best
available scientific evidence and that faculty identify any discussion of “off-label” or investigational use of
pharmaceutical products or medical devices.
DISCLOSURE OF THE FACULTY PRESENTING:
Drs. Barber, Mesinkovska, and Stetzer reported no financial relationship relevant to this activity.
Dr.Perriera performs training for Nexplanon and receives an honorarium from Merck.
Dr. Warren has reported an ownership interest in Cleveland Center for Eating Disorders.
DISCLOSURE OF THE PLANNING COMMITTEE MEMBERS:
Drs. Reed and Slotta reported no financial relationship relevant to this activity.
HOW TO OBTAIN CREDIT FOR THIS CONFERENCE
•
•
•
•
•
We are pleased to announce that complimentary transcripts are available on-line through the CME Program
website at: http://casemed.case.edu/cme/
Please go to the Credit Transcript button on the left-hand side of the page, click on it, and follow the prompts
for Online Transcripts.
We hope you will find this feature helpful in keeping track of the number of AMA PRA Category 1 Credits™ you
have through the CME Program office.
Credits normally appear within 30-45 days after attendance at a conference.
Physicians and nurses alike can view their credits on file with the CME Program through this website. If you
have any problems viewing your transcript, please call the CME Program at 216-983-1239.
ACKNOWLEDGEMENTS
We gratefully acknowledge Actavis Pharmaceuticals and Shionogi Pharmaceuticals for their support of this
program.